Skip to main content

Myriad Genetics Vectra Cardiovascular Risk

Myriad Genetics has launched Vectra Cardiovascular Risk, a report that estimates rheumatoid arthritis patients' risk of heart attack, stroke, or cardiovascular event-related death in the next three years. Vectra DA is a blood test that measures inflammation caused by RA, but now also incorporates three additional biomarkers to calculate a cardiovascular risk score for RA patients. The risk categories — low, borderline, intermediate, and high —align with the American College of Cardiology and American Heart Association's cardiovascular risk thresholds.